Market Tracker

01/20 5:03pm ET

DexCom Inc (NASDAQ:DXCM)

80.21
Delayed Data
As of 4:00pm ET
 -1.38 / -1.69%
Today’s Change
47.92
Today|||52-Week Range
96.38
+34.36%
Year-to-Date
Alcobra Leads Biotech Movers Early Friday
10:17am / TheStreet.com - Paid Partner Content
Why Sanchez Energy, DexCom, and Pandora Media Jumped Today
Jan 13 / MotleyFool.com - Paid Partner Content
The Pain Before the Gains: Cramer's 'Mad Money' Recap (Thursday 1/19/17)
Jan 19 / TheStreet.com - Paid Partner Content
Here's Why Insulet Corporation Rose by Double-Digits Today
Jan 13 / MotleyFool.com - Paid Partner Content
Here's a New List of Stocks That Show Bullish or Bearish Reversal Patterns
Jan 17 / TheStreet.com - Paid Partner Content
Why DexCom, Inc. Stock Surged Higher Today
Jan 13 / MotleyFool.com - Paid Partner Content
Bullish and Bearish Reversals in the Market
Jan 17 / TheStreet.com - Paid Partner Content
DexCom Looking Forward to Strong Revenues in Q4 and 2016
Jan 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close81.59
Today’s open81.60
Day’s range79.63 - 82.26
Volume1,225,069
Average volume (3 months)1,371,695
Market cap$6.9B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)-198.58%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book30.14

Competitors

 Today’s
change
Today’s
% change
TFXTeleflex Inc-0.63-0.38%
WSTWest Pharmaceutical ...-0.18-0.22%
ABMDAbiomed Inc-0.37-0.33%
MASIMasimo Corp-0.26-0.36%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts